BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24754723)

  • 1. Factors associated with health-related quality of life among patients with implantable cardioverter defibrillator: identification of foci for nursing intervention.
    Wong FM; Sit JW; Wong EM; Choi KC
    J Adv Nurs; 2014 Dec; 70(12):2821-34. PubMed ID: 24754723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator.
    Wong MF
    J Clin Nurs; 2017 May; 26(9-10):1328-1337. PubMed ID: 27859926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and psychological co-morbidities in children and adolescents with cardiac pacemakers and implanted defibrillators: a cohort study in Eastern Germany.
    Paech C; Ebel V; Wagner F; Stadelmann S; Klein AM; Döhnert M; Dähnert I; Gebauer RA
    Cardiol Young; 2020 Apr; 30(4):549-559. PubMed ID: 32279696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the patients' experiences of living with a subcutaneous implantable cardioverter defibrillator.
    Forman J; Baumbusch J; Jackson H; Lindenberg J; Shook A; Bashir J
    Eur J Cardiovasc Nurs; 2018 Dec; 17(8):698-706. PubMed ID: 29775072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing health-related quality of life in patients with an implantable cardioverter defibrillator: A systematic review.
    Wong F; Sit J; Wong E
    JBI Libr Syst Rev; 2012; 10(43):2785-2881. PubMed ID: 27820203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators.
    Magnusson P; Mörner S; Gadler F; Karlsson J
    Health Qual Life Outcomes; 2016 Apr; 14():62. PubMed ID: 27079917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of age on quality of life in implantable cardioverter defibrillator recipients.
    Hamilton GA; Carroll DL
    J Clin Nurs; 2004 Feb; 13(2):194-200. PubMed ID: 14723671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients.
    Zangger G; Zwisler AD; Kikkenborg Berg S; Kristensen MS; Grønset CN; Uddin J; Pedersen SS; Oldridge NB; Thygesen LC
    Eur J Prev Cardiol; 2018 Jan; 25(2):142-149. PubMed ID: 28952795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator.
    Thylén I; Wenemark M; Fluur C; Strömberg A; Bolse K; Årestedt K
    Eur J Cardiovasc Nurs; 2014 Apr; 13(2):142-51. PubMed ID: 24298191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
    Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
    J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
    Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
    Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators.
    DeMaso DR; Lauretti A; Spieth L; van der Feen JR; Jay KS; Gauvreau K; Walsh EP; Berul CI
    Am J Cardiol; 2004 Mar; 93(5):582-7. PubMed ID: 14996583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both mental and physical health predicts one year mortality and readmissions in patients with implantable cardioverter defibrillators: findings from the national DenHeart study.
    Berg SK; Rasmussen TB; Mols RE; Thorup CB; Borregaard B; Christensen AV; Cromhout PF; Ekholm O; Juel K; Thrysoee L
    Eur J Cardiovasc Nurs; 2019 Feb; 18(2):96-105. PubMed ID: 30114937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients.
    Flemme I; Johansson I; Strömberg A
    J Clin Nurs; 2012 Feb; 21(3-4):311-21. PubMed ID: 21951323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable Cardioverter Defibrillator Shocks and Psychological Distress: Examining the Mediating Roles of Implantable Cardioverter Defibrillator-Related Concerns and Perceived Control.
    Lee KS; Hammash MH; Kim JH; Kang KW; Miller J; McEvedy SM; Hwang SY; Moser DK
    J Cardiovasc Nurs; 2020; 35(1):66-73. PubMed ID: 31441803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Reported Outcomes in a Multidisciplinary Electrophysiology-Psychology Ventricular Arrhythmia Clinic.
    Sandhu U; Nguyen AT; Dornblaser J; Gray A; Paladino K; Henrikson CA; Kovacs AH; Nazer B
    J Am Heart Assoc; 2022 Aug; 11(15):e025301. PubMed ID: 35904213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Myocardial Bridge on Life-Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator.
    Okada K; Hibi K; Ogino Y; Maejima N; Kikuchi S; Kirigaya H; Kirigaya J; Sato R; Nakahashi H; Minamimoto Y; Kimura Y; Akiyama E; Matsuzawa Y; Iwahashi N; Kosuge M; Ebina T; Tamura K; Kimura K
    J Am Heart Assoc; 2020 Nov; 9(21):e017455. PubMed ID: 33094668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spanish implantable cardioverter-defibrillator registry. Seventh official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2010)].
    Alzueta J; Fernández JM
    Rev Esp Cardiol; 2011 Nov; 64(11):1023-34. PubMed ID: 21967881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.